Capacity and cost benefits of subcutaneous versus intravenous pertuzumab/trastuzumab: The EASE-SC studyMichiel Zietse, Frederick W. Thielen, Agnes Jager et al.|The Breast|2025Cited by 3
2320P Capacity and cost benefits of subcutaneous versus intravenous pertuzumab/trastuzumab: The EASE-SC studyMichiel Zietse, Frederick W. Thielen, Jun Hu et al.|Annals of Oncology|2025Cited by 0